Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Macrophage inhibitory cytokine-1 regulates melanoma vascular development.

Huh SJ, Chung CY, Sharma A, Robertson GP.

Am J Pathol. 2010 Jun;176(6):2948-57. doi: 10.2353/ajpath.2010.090963. Epub 2010 Apr 29.

2.

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.

Sharma A, Trivedi NR, Zimmerman MA, Tuveson DA, Smith CD, Robertson GP.

Cancer Res. 2005 Mar 15;65(6):2412-21.

3.

Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.

Sharma A, Madhunapantula SV, Gowda R, Berg A, Neves RI, Robertson GP.

Am J Pathol. 2013 Apr;182(4):1151-62. doi: 10.1016/j.ajpath.2012.12.019. Epub 2013 Feb 12.

4.

Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.

Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M, Smith NB, Robertson GP.

Cancer Res. 2008 Sep 15;68(18):7638-49. doi: 10.1158/0008-5472.CAN-07-6614.

5.

Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth.

Hao H, Muniz-Medina VM, Mehta H, Thomas NE, Khazak V, Der CJ, Shields JM.

Mol Cancer Ther. 2007 Aug;6(8):2220-9.

6.
7.

Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.

Yeh AH, Bohula EA, Macaulay VM.

Oncogene. 2006 Oct 26;25(50):6574-81. Epub 2006 May 22.

PMID:
16715137
8.

Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

Cheung M, Sharma A, Madhunapantula SV, Robertson GP.

Cancer Res. 2008 May 1;68(9):3429-39. doi: 10.1158/0008-5472.CAN-07-5867.

9.

GAB2 induces tumor angiogenesis in NRAS-driven melanoma.

Yang Y, Wu J, Demir A, Castillo-Martin M, Melamed RD, Zhang G, Fukunaga-Kanabis M, Perez-Lorenzo R, Zheng B, Silvers DN, Brunner G, Wang S, Rabadan R, Cordon-Cardo C, Celebi JT.

Oncogene. 2013 Aug 1;32(31):3627-37. doi: 10.1038/onc.2012.367. Epub 2012 Aug 27.

10.

Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation.

Liang S, Sharma A, Peng HH, Robertson G, Dong C.

Cancer Res. 2007 Jun 15;67(12):5814-20.

11.
12.

Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS.

Jiang CC, Lai F, Tay KH, Croft A, Rizos H, Becker TM, Yang F, Liu H, Thorne RF, Hersey P, Zhang XD.

Cell Death Dis. 2010 Sep 2;1:e69. doi: 10.1038/cddis.2010.48.

13.

Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.

Roda JM, Sumner LA, Evans R, Phillips GS, Marsh CB, Eubank TD.

J Immunol. 2011 Aug 15;187(4):1970-6. doi: 10.4049/jimmunol.1100841. Epub 2011 Jul 15.

14.

B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells.

Cui Y, Guadagno TM.

Oncogene. 2008 May 15;27(22):3122-33. Epub 2007 Dec 10.

PMID:
18071315
15.

The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.

Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):421-9. doi: 10.1167/iovs.09-3974. Epub 2009 Aug 6.

PMID:
19661225
17.

AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma.

Hu W, Jin L, Jiang CC, Long GV, Scolyer RA, Wu Q, Zhang XD, Mei Y, Wu M.

Cell Death Dis. 2013 Nov 7;4:e914. doi: 10.1038/cddis.2013.441.

18.

17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.

Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.

Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2348-56. doi: 10.1167/iovs.07-1305. Epub 2008 Feb 15.

PMID:
18281615
19.

Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.

Mimeault M, Batra SK.

J Cell Physiol. 2010 Sep;224(3):626-35. doi: 10.1002/jcp.22196. Review.

20.

Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.

Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF.

Cancer Res. 1996 Jan 1;56(1):172-81.

Items per page

Supplemental Content

Write to the Help Desk